Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Hematology"
DOI: 10.1007/s00277-019-03663-5
Abstract: Dear Editor, To improve results in transplant-eligible multiple myeloma (MM) patients, the combination of busulfan and melphalan (BUMEL) has been used as an alternative conditioning regimen to standard-dose melphalan 200 mg/m (MEL200) [1–4]. The results… read more here.
Keywords: busulfan; bumel; control; multiple myeloma ... See more keywords